Cancer Letters
Volume 203, Issue 2 , Pages 199-207 , January 2004

Glutathione S-transferase P1 has protective effects on cell viability against camptothecin

  • Takamitsu Hara

      Affiliations

    • Department of Radiology, Yokohama City University School of Medicine, Yokohama City, Japan
    • ,
  • Takeo Ishii

      Affiliations

    • Department of Pulmonary Medicine, Yokohama City University Medical Center, 4-57, Urahune-cho, Minami-ku, Yokohama City 232-0024, Japan
    • Research Fellow of the Japan Society for the Promotion of Science.
    • ,
  • Mina Fujishiro

      Affiliations

    • Department of Pulmonary Medicine, Yokohama City University Medical Center, 4-57, Urahune-cho, Minami-ku, Yokohama City 232-0024, Japan
    • ,
  • Michiaki Masuda

      Affiliations

    • Department of Microbiology, Dokkyo University School of Medicine, Dokkyo, Japan
    • ,
  • Takaaki Ito

      Affiliations

    • Department of Pathology, Yokohama City University School of Medicine, Yokohama City, Japan
    • ,
  • Jun Nakajima

      Affiliations

    • Department of Cardiothoracic Surgery, University of Tokyo, Tokyo, Japan
    • ,
  • Tomio Inoue

      Affiliations

    • Department of Radiology, Yokohama City University School of Medicine, Yokohama City, Japan
    • ,
  • Takeshi Matsuse

      Affiliations

    • Department of Pulmonary Medicine, Yokohama City University Medical Center, 4-57, Urahune-cho, Minami-ku, Yokohama City 232-0024, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-45-261-5656; fax: +81-45-241-2812

Received 17 June 2003 ,Revised 25 August 2003 ,Accepted 1 September 2003.

References 

  1. Mansouri A, Henle KJ, Nagle WA, Moss AJ. Tumor cell drug resistance and its reversal. SAAS Bull. Biochem. Biotechnol. 1990;3:91–96
  2. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, et al.  Expression of a multidrug resistance gene in human cancer. J. Natl Cancer Inst. 1989;81:116–124
  3. Schecter RL, Alaoui-Jamali MA, Batist G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem. Cell Biol. 1992;70:349–353
  4. Grant R, Ironside JW. Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma. J. Neurooncol. 1995;25:1–7
  5. Eastman A, Schulte N, Sheibani N, Sorenson CM. Mechanisms of resistance to platinum drugs. In:  Nicolini M editors. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Boston: Martinus Nijhoff Publishing; 1988;p. 178–196
  6. Liu LF, Desai SD, Li TK, Mao Y, Sun M, Sim SP. Mechanism of action of camptothecin. Ann. NY Acad. Sci. 2000;922:1–10
  7. Rothenberg ML. CPT-11: an original spectrum of clinical activity. Semin. Oncol. 1996;23:21–26
  8. Rosen LS. Irinotecan in lymphoma, leukemia, and breast, pancreatic, ovarian, and small-cell lung cancers. Oncology (Huntingt). 1998;12:103–109
  9. Saleem A, Edwards TK, Rasheed Z, Rubin EH. Mechanism of resistance to camptothecin. Ann. NY Acad. Sci. 2000;922:46–55
  10. Mannervik B. The isozymes of glutathione S-transferase. Adv. Enzymol. 1985;57:357–417
  11. Shea TC, Kelley SL, Henner WD. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res. 1988;48:527–533
  12. Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, et al. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res. 1996;56:3577–3582
  13. O'Brien M, Kruh GD, Tew KD. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J. Pharmacol. Exp. Ther. 2000;294:480–487
  14. Saburi Y, Nakagawa M, Ono M, Sakai M, Muramatsu M, Kohno K, et al. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. Cancer Res. 1989;49:7020–7025
  15. Ishii T, Matsuse T, Igarashi H, Masuda M, Teramoto S, Ouchi Y. Tobacco smoke reduces viability in human lung fibroblasts: protective effect of glutathione S-transferase P1. Am. J. Physiol. Lung Cell Mol. Physiol. 2001;280:L1189–L1195
  16. Holyoake T, Jian X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood. 1999;94:2056–2064
  17. Nakashio A, Fujita N, Rokudai S, Sato S, Tsuruo T. Prevention of phosphatidylinositol 3′-kinase-akt survival signaling pathway during topotecan-induced apoptosis. Cancer Res. 2000;60:5303–5309
  18. Scott L, Lamb J, Smith S, Wheatley DN. Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br. J. Cancer. 2000;83:800–810
  19. Kobune M, Xu Y, Baum C, Kelley MR, Williams DA. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N′,N″- triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo. Cancer Res. 2001;61:5116–5125
  20. Goto S, Ihara Y, Urata Y, Izumi S, Abe K, Kondo T. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi. Fed. Am. Soc. Exp. Biol. J. 2001;15:2702–2714
  21. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995;30:445–600
  22. Johansson AS, Stenberg G, Widersten M, Mannervik B. Structure–activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J. Mol. Biol. 1998;278:687–698
  23. Colvin OM, Friedman HS, Gamcsik MP, Fenselau C, Hilton J. Role of glutathione in cellular resistance to alkylating agents. Adv. Enzyme Regul. 1993;33:19–26
  24. Dirven HA, van Ommen B, van Bladeren PJ. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res. 1994;54:6215–6220
  25. Gamcsik MP, Kasibhatla MS, Adams DJ, Flowers JL, Colvin OM, Manikumar G, et al.  Dual role of glutathione in modulating camptothecin activity: depletion potentiates activity, but conjugation enhances the stability of the topoisomerase I-DNA cleavage complex. Mol. Cancer Ther. 2001;1:11–20
  26. Seimiya H, Mashima T, Toho M, Tsuruo T. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 1997;272:4631–4636
  27. Lauricella M, Calvaruso G, Carabillo M, D'Anneo A, Giuliano M, Emanuele S, et al.  pRb suppresses camptothecin-induced apoptosis in human osteosarcoma Saos-2 cells by inhibiting c-Jun N-terminal kinase. Fed. Eur. Biochem. Soc. Lett. 2001;499:191–197
  28. Costa-Pereira AP, McKenna SL, Cotter TG. Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis. Br. J. Cancer. 2000;82:1827–1834
  29. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, et al.  Regulation of JNK signaling by GSTp. Eur. Mol. Biol. Org. J. 1999;18:1321–1334
  30. O'Brien M, Kruh GD, Tew KD. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J. Pharmacol. Exp. Ther. 2000;294:480–487
  31. Miyazaki M, Kohno K, Saburi Y, Matsuo K, Ono M, Kuwano M, et al.  Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. Biochem. Biophys. Res. Commun. 1990;166:1358–1364

PII: S0304-3835(03)00589-5

doi: 10.1016/j.canlet.2003.09.005

Cancer Letters
Volume 203, Issue 2 , Pages 199-207 , January 2004

Article Tools

* Image Usage & Resolution